Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
EUR 86,45
Anzahl: 3 verfügbar
In den WarenkorbZustand: New.
EUR 83,49
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. Claudio Carini, Sandeep Menon, Mark ChangThe Future of Clinical Research and Health Care: From Empirical to Precision MedicineClinical and Statistical Considerations in Personalized Medicine explores recent advances rela.
Anbieter: PBShop.store US, Wood Dale, IL, USA
HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.
Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes Königreich
EUR 170,99
Anzahl: 1 verfügbar
In den WarenkorbHRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 199,44
Anzahl: 1 verfügbar
In den WarenkorbHardcover. Zustand: Brand New. 376 pages. 9.25x6.25x1.00 inches. In Stock.
Anbieter: moluna, Greven, Deutschland
Zustand: New. Claudio Carini, Sandeep Menon, Mark ChangThe Future of Clinical Research and Health Care: From Empirical to Precision MedicineClinical and Statistical Considerations in Personalized Medicine explores recent advances rela.
Anbieter: preigu, Osnabrück, Deutschland
Buch. Zustand: Neu. Clinical and Statistical Considerations in Personalized Medicine | Claudio Carini (u. a.) | Buch | Einband - fest (Hardcover) | Englisch | 2014 | CRC Press | EAN 9781466593862 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu.
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. Neuware - Despite the vast amount of literature on biomarkers, there is no comprehensive book that integrates the clinical and statistical components. This book is one of the first to incorporate both the clinical and statistical aspects of biomarkers in the personalized medicine paradigm. Leading clinicians, biostatisticians, regulators, commercial professionals, and researchers address the opportunities and challenges in successfully applying biomarkers in drug discovery and preclinical and clinical development. They cover a wide spectrum of personalized medicine-related topics, including epigenetics, adaptive designs, statistical methods, regulatory issues, and more.